Moxifloxacin Hydrochloride Tablet, Film Coated
Product Images NDC 57237-156

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin Hydrochloride (NDC 57237-156). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Moxifloxacin Fig1)

FDA Label Image

Package Label-principal Display Panel (400 mg (30 Tablets Bottle))

Rising Health LLC, a company based in Saddle Brook, NJ, distributes each film-coated tablet containing 400 mg of moxifloxacin hydrochloride USP. This medication is made in India and is used for typical dosages, which can be found in the accompanying literature. The pharmacist should store this medicine at a controlled room temperature between 20°C to 25°C (68°F to 77°F) with low humidity. A medication guide is provided separately for each patient. The revision date for the tablets is 07/2020. The dotted lines in the text should not be printed.*

FDA Label Image

Structure (Moxifloxacin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.